We have expanded hours beginning October 6 to better serve you!  Learn more

Faculty Publications

MetroHealth’s Gastroenterology team is dedicated to research, sharing remarkable discoveries with the world.

These are just some of the results our team has published in medical journals between 2016 and 2023.

  1. Achalu S, Berry R, Zhuo Jet al. Development and modification of a dysphagia question prompt list to improve patient-physician communication: incorporating both esophageal expert and patient perspective. Neurogastroenterol Motil 2023.
  2. El Hage Chehade N, Fu Y, Ghoneim S, Shah S et al. The Association between obstructive sleep apnea and GERD: A systematic review and Meta-analysis J Gastroenterol Hepatol 2023 (in press).
  3. Fass R. Gastroesophageal reflux disease. Reply. N Eng J Med 2023; 388:864.
  4. Ghoneim S, Wong J, El Hage Chehade n Ganocy SJ, Chitsaz E, Fass R. Diagnostic accuracy of the proton pump inhibitor test for detection of GERD: A symptomatic review and meta­ analysis. J Clin Gastroenterol 2023;57:380-388.
  5. Kurin M, Adil SA, Damjanovska S, Tanner S, Greer K. Clinical Characteristics of Patients With Ineffective Esophageal Motility by Chicago Classification Version 4.0 Compared to Chicago Classification Version 3.0. J Neurogastroenterol Motil. 2023 Jan 30;29(1):38-48.
  6. Liu BD, Starkey M, Virani A, Pichette SL, Fass S, Song G. Review article: Functional dyspepsia and pregnancy-Effects and management in a special population. Aliment Pharmacol Ther. 2023 May 2. doi: 10.1111/apt.17534. Epub ahead of print. PMID: 37129241.
  7. Mohammed A, Trujillo S, Ghoneim S, Paranji N, Waghray N. Small Bowel Adenocarcinoma: a Nationwide Population-Based Sh1dy. J Gastrointest Cancer. 2023 Mar;54(1):67-72.
  8. Saleh S. et al. Effect of hormone therapy on GERD, Barrett's Esophagus an esophageal stricture in post-menopausal women. Clin Gastroenterol Hepatol 2023;21:549-51.
  9. Shah R, Kurin M, Satyavada S, Ismail M, Smith Z, Davitkov P, Isenberg G, Gofu1mukkala R, Faulx A, Falck-Ytter Y, Chak A. Evidence-Based Cognitive Endoscopy Simulators: Do They Exist? A Systematic Search and Evaluation of Existing Platforms. Dig Dis Sci. 2023 Mar;68(3):744-749.
  10. Shibli F, Jim YD, Fass R. Aortic aneurism presenting as deglutition syncope. Cureus 2023 Open access. DOI:10.7759/cureus.39196.
  11. Simadibrata D et al. Diagnostic accuracy of GERD for GERD: A systematic review and Meta analysis" Neurogastroenterol Motil 2023 (in press).
  12. Song G, Trujillo S, Fu Yet al. Transcutaneous electrical stimulation for gastrointestinal Motility disorders. Neurogastroenterol Motil 2023.
  13. The Mexican Association of Neurogastroenterology and Motility (AANH) - Third international postgraduate course "Neurogastro 2023. "Is classification by Phenotype of GERD still useful?", "Chest pain of esophageal origin-the experts view" and "P-CABs Pharmacology and Tegoprazam strength", Mexico City, Mexico March 2023.
  14. Wang X, Wright Z, Patton-Tackett ED, Song G. The Relationship between Gastroesophageal Reflux Disease and Clu·onic Kidney Disease. Journal of PersL1nalized Medicine. 2023; 13(5):827. https:// doi.org/10.3.'.\90/jpm13050827
  15. Yadlapati R, Gyawali cP, Carlson DA, Pandolfini Je, Fass, et al. Inter-and Intra-rates agreement of functional imaging probe metrics of healthy subjects. Neurogastroenterol Motil 2023;35:e14505.
  1. Chen J W, Klan A, Chokski Rv et al. Interrater reliability of functional lumen imaging probe (FLIP) Panometry and high resolution manometry for assessment of esophageal motility disorders. Am J Gastroenterol 2022.
  2. Cheng J, Song G, Guan Q, Shen T. Development of an automated transcutaneous electrical acustimulation device synchronized with respiration for treating gastroesophageal reflux diseases. Proceedings of 2022 Design of Medical Device Conference; April 11-14, 2022; Minneapolis, MN, USA.
  3. Fang S, Fu Y, Du S, Wang L, Qing X, Luo X, Song G, Yang Y, Wei W. The role of the endoscopic grading of gastric intestinal metaplasia in assessing gastric cancer risk: A systematic review and meta-analysis. Front Oncol. 2022 Nov 8;12:1018248. doi: 10.3389/ fonc.2022.1018248.PMID: 36425561; PMCID: PMC9679375.
  4. Fass Oz, Fass R. Treatment of nonachalasic esophageal motor disorders, Gastroenterology & Endoscopy News 2022, April, 1-8.
  5. Fass R, Clinical practice - Gastroesophageal Reflux Disease. N Eng J Med 2022; 387:1207-16. Yadlapati R, Gawron A, Gyawali CP, Cheng, Clarke J, Fass R et al. Clinical role of ambulatory reflux monitoring in PPI non-responders. Aliment Pharmacel Ther 2022;56:1274- 1283.
  6. GERD Roundtable: Applying Guidelines to clinical practice. Falk GW, Fas R, Patel A, Vaezi M. Gastroenterology and Endoscopy News 2022, May 2022.
  7. Jiang T, Niu R, Liu Q, Fu Y, Luo X, Zhang T, Wu B, Han J, Yang Y, Su X, Chen JDZ, Song G, Wei W. Wenshen-Jianpi prescription, a Chinese herbal medicine, improves visceral hypersensitivity in a rat model of IBS-D by regulating the MEK/ERK signal pathway. Front Pharmacol. 2022 Sep 23;13:955421. doi: 10.3389/ fphar.2022.955421. Erratum in: Front Pharmacol. 2022 Nov 21;13:1075874. PMID: 36210803; PMCID: PMC9540386.
  8. Kamal A, Achkar E, Carlson D, Clarke Jet al. Question prompt list as a communication tool for adults with GERD. Incorporation of Patients' Perspectives. J Clin Gastroenterol 2022;56:565-70.
  9. Kamionkowski S, Shibli F, Ganocy S, Fass R. The relationship between GERD and Autism spectrum disorder in adult patients. Neurogastroenterol Motil 2022;11:S1542.
    Kim Y, Shibli F, Fu Y, Song G, Fass R. Multiple Sclerosis is associated with achalasia and distal esophageal spasm. J Neurogastroenterol Motil 2022.
  10. Kurin M, Elangovan A, Alikhan MM, Al Dulajian B, Silver E, Kaelber DC, Cooper G. Irritable bowel syndrome is sb'ongly associated ,vith the primary and idiopathic mast cell disorders. Neurogash'oenterol Motil. 2022 May;34(5):e14265.
  11. Liu B, et al. The effect of combined oral contraceptives and Nexplanon on GERD in premenopausal women: A nationwide database analysis. Neurogastroenterol Motil 2022.
  12. Liu J, Song G, Huang Y, Lv C, Wang Y, Wu D, Sun C, Jing M, Yu Y. Placebo Response Rates in Acupuncture Therapy Trials for Functional Dyspepsia: A Systematic Review and Meta­ Analysis. J Clin Gastroenterol. 2022 Apr 1;56(4):299-310. doi: 10.1097/MCG.0000000000001679. PMID: 35180148; PMCID: PMC8900996.
  13. Liu J, Wang W, Tian J, Lv C, Fu Y, Fass R, Song G, Yu Y. Sleep Deficiency Is Associated With Exacerbation of Symptoms and Impairment of Anorectal and Autonomic Functions in Patients With Functional Constipation. Front Neurosci. 2022 Jul 7;16:912442. doi: 10.3389/fnins.2022.912442. PMID: 35873821; PMCID: PMC9301120.
  14. Loutfy A, Kurin M, Shah R, Davitkov P. Characterization of American teduglutide consumers from 2015 to 2020: A large database study. JPEN J Parenter Enteral Nufr. 2022 Mar;46(3):646- 651.
  15. Mohammed A, Ghoneim S, Paranji N, Waghray N. Quantifying risk factors for microscopic colitis: A nationwide, reh·ospective cohort study. Indian J Gasfroenterol. 2022 Apr;41(2):181- 189.
  16. O'souza SM, Fass R, Shibli F, Johnson DA. Sleep and Gastrointestinal Health. In Kryger, Roth, Goldstein and Demat (eds). Principles and Practice of Sleep Medicine, 7th. Edition, Elsevier 2022, Philadelphia 1557-1564.
  17. Remes - Troche JM, Fass R. Esophageal Hypersensitivity. In Rao, Parkman and McCullum (eds). Handbook of Gastrointestinal Motility and Functional Disorders, second edition, slack (in press).
  18. Shah R, Satyavada S, Kurin M, Ismail M, Smith ZL, Davitkov P, Isenberg G, Raju GS, Faulx A, Falck-Ytter Y, Chak A. Meet EBE: The Development of an Evidence-Based Endoscopy Simulator. Clin Gastroenterol Hepatol. 2022 May;20(5):e1180-e1187.
  19. Shibli F, Fass 0, Teramoto OM, Remes-Troche JM, Rangan V, Kurin M, Fass R. Hypocontractile Motility disorers and hiatal hernia size are predictors for long segment Barrett's esophagus. J Neurogasb·oenterol Motil 2022 2023;29:31-7 (received an editorial) Kamal AN, Dar SI, Back JM, Clarke JO, Lechien JR et al. "Best practices in treatment of laryngolaryngoeal reflux disease - A multidisciplinary modified Delphi Study". Dig Dis Sci 2022.
  20. Shibli F, Jim YD, Fass R. Aortic aneurism presenting as deglutition syncope. Cureus 2023 Open access. DOI:10.7759/cureus.39196.
  21. Shibli F, Sandhu DS, Fass R. the discrepancy between subjective and objective clinical endpoints in gastroesophageal reflux disease. J Clin Gastroenterol 2021;56:375-83.
  22. Ugwuegbu, 0, Shibli F, Kim Yeseong, Raugan V, Kurin M, Ayoub F, Ganocy S, Keuitt R, Fass R. The impact of chronic cannabis use on esophageal motility in patients referred for esophageal manometry. J Clin Gastroenterol 2022 (in press).
  23. Wong RJ, Jain MK, Therapondos G, Niu B, Kshirsagar 0, Thamer M. Low Rates of Hepatitis B Virus Treatment Among Treatment-Eligible Patients in Safety-Net Health Systems. J Clin Gastroenterol. 2022 Apr 1;56(4):360-368.
  24. Yamasaki T, Fass R. Functional Heartburn. Gastroenterology & Endoscopy News 2018, May, 1-8.The Israeli Neurogastroenterology Society and Israeli Gastroenterological Association GERD Guidelines for the primary care physician member of the GI forum.
 

 

  1. Bredenoord AJ, Babaei A, Carlson D, Omari T, Akiyama J, Yadlapati R, Pandolfino JE, Richter J, Fass R, Esophago-gastric junction outflow obstruction. Neurogastroenterol Motil 2021; 33:el4193.
  2. Dickman R, Levy S, Perets TT, Faucher M, Baltin D et al. Effect of transcutaneous electrical stimulation system on esophageal acid exposure in patients non-responsive to once daily PPI - A proof of concept study. Gastroenterol Rep 2021;9:323-328.
  3. Elangovan A, Shibli F, Fass R. Alterations in integrated residual pressure (IRP) during successive swallows in subjects with normal manometry versus those with esophogastric junction outflow obstruction (EGJOO). J Neurogastroenterol Motil 2021;27:185-190 (received an editorial).
  4. Fass OZ, Fass R. Diagnosis of esophageal motor disorders, Gastroenterology & Endoscopy News 2021 October, 41-51.
  5. Fass R, Boeckxstaens GE, El-Serag H, Rosen R, Sifrirn D, Vaezi MF. Gastroesophageal reflux disease. Nat Rev Dis Prim 2021; 7(56):1-23.
  6. Issak A, Elangovan A, Ferguson RD, Waghray N, Sandhu DS. Underutilization of prophylactic rectal indomethacin and pancreatic duct stent for prevention of post-ERCP Pancreatitis. Enclose Int Open. 2021 Jul;9(7):E979-E985.
  7. Ka1nionkowski S, Issak A, Zhang C, Wang Y, Kyprianou A. A Solitary Sigmoid Pe1ineurioma in an Otherwise Healthy 30-Year-Old Male. Cureus. 2021 May 18;13(5):e15104.
    Kamal A, Kathpalia P, Bredenoord AJ, Castell DO, Clarke JO et al. Development of quality indicators for the diagnosis and management of achalasia. Neurogastroenterol Motil 2021;33:e14118.
  8. Kim Y, Wang J, Shibli F, Fass R. chronic use of ramitidine is not associated with an increased risk of developing gastrointestinal malignancies. Aliment Pharmacol Ther, 2021; 54:606-615.
  9. Kurin M, Anderson A, Ramos Rivers C, Kouu·oumpakis F, Centa P, Bender-Heine J. Kozak G, Kramer E, O'Keefe SJ, v\Thitcomb DC, Levinthal DJ, Koutrnubakis IE< Dunn MA, Hashash JG, Binion DG. Clinical Characteristics of Inflainmatory Bowel Disease Patients Requiring Long-Term Parenteral Support in the Present Era of Highly Effective Biologic Therapy. JPEN J Parenter Enteral Nuh'. 2021 Jul;45(5):1100-1107.
  10. Kurin M, Jin-Dominguez F, Sclair S. Penetrating Toothpick in the Portal Vein Resulting in Refractory Multifocal Liver Abscesses. ACG Case Rep J. 2021 Jun 7;8(6):e00615.
  11. Kurin M, Mirarchi F. The living will: Patients should be informed of the risks. J Healthc Risk Manag. 2021 Oct;41(2):31-39.
  12. Kurin, M, Shibli F, Kitayama Y, Kim Y, Fass R. Sorting Out The Relationship between GERD and Sleep. Curr Gastroenterol Rep. 2021;23:15.
  13. Mohammed A, Paranji N, ch.en PH, Niu B. COVID-19 in Chronic Liver Disease and Liver Transplantation: A Clinical Revie,v. J Clin Gastroenterol. 2021 Mar 1;55(3):187-194.
  14. Mohammed A, Shariati F, Paranji N, Waghray N. Primary follicular lymphoma of colon: A case series and review of literature. Clin Case Rep. 2021 Jul 23;9(7):e04486.
  15. O'Neil J, Winter E, Hemmond C, Gittleman H, Fass R. Will they Show? Predictors of nonattendance for scheduled screening colonoscopies at a safety net hospital. J Clin Gastroenterol 2021;55:52-58.
  16. Patel D, Fass, Vaezi M. NERD and functional heartburn: untangling the burn. Clin. Gastroenterol Hepatol, 2021;19:1314-26.
  17. Remes - Troche JM, Fass R. Esophageal Hypersensitivity. In Rao, Parkman and McCullum (eds). Handbook of Gastrointestinal Motility and Functional Disorders, second edition, slack (in press).
  18. Sandhu D.S., Shibli F., Fass R. (2021) Endoscopic Radiofrequency (Stretta) in the management of Gastroesophageal Reflux Disease (GERD). In Testani P.A., Inoue H., Wallace M.B. (eds) Gastrointestinal and Pancreatico-Biliary diseases: Advanced Diagnostic and Therapeutic Endoscopy. Springer, Cham. https://doi.org/10.1007/978-3-030-29964-4 41-1.
  19. Shah A, Shibli F, Kitayama Y, Fass R. The natural course of gastroesophageal reflux disease - A critical appraisal. J Clin Gastroenteral 2021;55:12-20.
  20. Shibli F, Fass R. Endoscopic Anti-reflux procedures. Ready for Clinical Use?. Curr Treat Opt Gastroenterol 2021; 19: 399-420.
  21. Shibli F, Fass R. Refractory Heartburn - Reflux hypersensitivity and Functional Heartburn. In Richter and Castell (eds). The Esophagus, 6th edition, 2021 John Wiley & Sons Ltd.
  22. Shibli F, Sandhu DS, Fass R. the discrepancy between subjective and objective clinical endpoints in gastroesophageal reflux disease. J Clin Gastroenterol 2021;56:375-83.
  23. Tawil J, Fass R, El Lado Mas sensible del esophago en relacion al reflujo gastroesofagico ensenanzas de Rome IV. Acta LatinoAmerica del Gastroenterologia, 2020;50:72-81.
  24. Yadlapati R and Chicago Classification Group. Esophageal Motility disorders on high resolution manometry: Chicago Classification version 4.0. Neurogastroenterol Motil 2021;33(1): e14058.
  25. Zerbib F, Bredenoord AJ, Fass R, Kahrilas P, Roman Set al. ESNM/ ANMS consensus paper: Diagnosis and Management of Refractory Gastroesophageal reflux disease Neurogastroenterol Motil 2021;33:e14075.
  26. Zhuo Jet al. Development of a preliminary question prompt list as a communication tool for adults with Achalasia: A modified Delphi study. J Clin Gasteroenterol 2021;2:159-164.

 

  1. Desai A, Twohig P, Waglu·ay A, Gonakoti S, Skeans J, Waghray N, Sandhu DS. Stop Blaming the Weatherman! A Retrospective Study of Endoscopy Show Rates at a Midwest Urban Safety­ Net Hospital. J Clin Gasb:oenterol. 2020 Nov /Dec;54(10):879-883.
  2. Eisa M, Sandhu A, Gonocy SJ, Fass R. The risks of acute myocardial infarction in patients with gastroesophageal reflux disease. J Neurogastroenterol Motil 2020;26:471-76. (received an editorial).
  3. Fass R, Teramoto 0, Kurin M, Khalessi A, Kitayama Y, Shibli F. Esophageal function abnormalities in patients with Barrett's Esophagus. J Clin Gastroenterol 2020;54:485-92.
    Fass R, Zerbib F, Gywali CP. AGA clinical practice update: Functional heartburn, Gastroenterology 2020 ;158:2286-93.
  4. Fass R. Audio Digest "Functional dysphagia, August 2020.
  5. Fass R. Audio Digest "Refractory GERD", June 2020. Fass R. Audio Digest "Noncardiac chest pain, July 2020.
  6. Ghoneim S, Shah A, Dhorepatil A, butt MU, Waghray N. The Risk of Cerebrovascular Accidents in Inflammatory Bowel Disease in the United States: A Population-Based National Study. Clin Exp Gastroenterol. 2020 May 4;13:123-129.
  7. Kamal A, Katzka DA, Achkar E, Carlson D, Clarke Jet al. Simplifying patients' clinic experience - Development of a question prompt list for adults with GERD: A Modified Delphi study. J Clin Gastroenteral 2020; 54:857-63.
  8. Kim Y, Ganocy S, Fass R. Proton pump inhibitor use and the development of new ischemic heart disease in non-cardiac chest pain patients. Neurogastroenterol Motil 2020; 32: e13844.
  9. Kurin M, Cooper G. Irritable bowel syndrome with diarrhea: Treatment is a work in progress. Cleve Clin J Med. 2020 Jul 31;87(8):501-511.
  10. Orr WC, Fass R, Sundaram SS, Scheimann AO. Interplay between sleep alteration and gastrointestinal and liver disease - under respected value of a good night's rest. Lancet Gash·oenterol 2020;5:616-24.
  11. Patel D, Fass R. "GERD reporters Guide"- IFFGD, November 2020.
  12. Sandhu A, Eisa M, Yamusalci T, Shibli F, Fass R. Durability and modifiers of objectively diagnosed esophageal motor disorders. Ad ther, 2020;37:2560-71.
  13. Shah R, Satyavada S, Ismail M, Kurin M, Smith ZL, Cooper GS, Chak A. COVID-19 pandemic through the lens of a gastroenterology fellow: looking for the silver lining. Gastrointest Enclose. 2020 Aug;92(2):394-398.
  14. Shibli F, Skeans J, Yamasaki T, Fass R. Gastroesophageal reflux disease and sleep - An important relationship that is commonly overlooked. J Clin Gastroenterol 2020; 54:663-74.
  15. Shibli F., Kitayama Y., Fass R. Novel therapies for gastroesophageal reflux disease: beyond proton pump inhibitors. Curr Gastroenteral Rep 2020;22:16.
  16. Tawil J, Fass R, El Lado Mas sensible del esophago en relacion al reflujo gastroesofagico ensenanzas de Rome IV. Acta LatinoAmerica del Gastroenterologia, 2020;50:72-81.
  17. Twohig PA, Desai A, skeans J, Waghray N. Quantifying risk factors for ischemic colitis: A natiornvide, reh·ospective cohort sh1dy. Indian J Gastroenterol. 2020 Aug;39(4):398-404.
  18. Vaezi M, Fass R, Vakil N, Mittleman RS et al. IW-3718 for persistent gastroesophageal reflux disease - a double blind, placebo-controlled trial. Gastroenterology 2020 ;158:2093-103.
  19. Yamasaki T, Sakiani S, Marodey-Romero C, Mehta R et al. Barrett's esophagus patients are becoming younger - analysis of a large national dataset Esophagus 2020;17:190-6
  1. Abdallah J, George N, Yamasaki T, Ganocy S, Fass R. Most patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy also have functional esophageal disorders. Clin Gastroenteal Hepatol 2019;17:1073-1080.
  2. Fass OZ, Fass R. Functional dysphagia. In Patel, Kavitt, Vaezi (eds). Evaluation and management of dysphagia: An evidence-based approach. Springer Nature Cham, Switzerland.; 2019: 201-18.
  3. Fass OZ, Fass R. Overlap between GERD and functional esophageal disorders - a pivotal mechanism for treatment failure. Cur treat opt Gastroenterol 2019;17:161-164.
  4. Fass R, Shibli F, Tawil J. Diagnosis and Management of functional chest pain in the Rome IV era. J Neurogastroenterol Motil 2019; 25:487-98.
  5. Fass R, Shibli F. Reflux Hypersensitivity versus nonerosive reflux disease: Diagnostic and therapeutic considerations 2019 Mexico City, Mexico, 91-104.
  6. Fass R, Tawil J. Hipersensibilidad al reflujo y Pirosis funcional. In Schmulson MJ (ed). 100 freguntas clave on Trastoronos funcionales Gastrointestinales. Permanyer 2019, Mexico City, Mexico 1-9.
  7. Fass R. Endoscopic treatments for GERD. Gastroenterol Hepatol 2019:15:555-57.
  8. Fass R. Esophageal Disorders Functional, 2020. In Kuipers ET (ed) Encyclopedia of Gastroenterology, 2nd Edition 2019, 341-356. Oxford: Academic Press.
  9. Fass R. Gastroesophageal reflux disease-related non cardiac chest pain. In Soto, Sobrino, Remes (eds). Gastro-esophageal reflux disease. ASECOM 2019, Mexico City, Mexico, 269-66.
  10. Ghoneim S, shah A, Dalal S, Landsman M, Kyprianou A. Black Esophagus in the Setting of Diabetic Ketoacidosis: A Rare Finding from Our Institution. Case Rep Gastroenterol. 2019 Nov 20;13(3):475-480.
  11. Kurin M, Fass R. Management of Gastroesophageal Reflux Disease in The Elderly Patient. Drug Age 2019; 25: 687-98.
  12. Kurin M, Katz, J, Kokdish E, Laslmer B. Informed Consent in IBD Trials: \Vhere We Are and here We Need to Go. Inflamm Bowel Dis. 2019 Jun 18;25(7):1115-1119.
  13. Laique S, Singh T, Dornblaser D, Gadre A, Rangan V, Fass R, Kirby D, Chatterjee S, Gabbard S. Patient characteristics and associated systematic diseases in patients with esophageal absent contractility. J clin Gastroenterol 2019;53:184-190.
  14. Sandhu D, Fass R. Stress and Gastroesophageal reflux disease. NTSN HS 2018, 54(2):10-15 Sandhu DS, Fass R. Stretta therapy in the management of gastroesophageal reflux disease (GERD). Ann Esoph 2019; 2:1:1-11.
  15. Shal, AR, Landsman M, Waghray N. A Dire Presentation of Diabetic Ketoacidosis with "Black Esophagus. Cureus 2019 May 27;11(5):e4761.
  16. Waghray A, Waghray N, Perzynski AT, Votruba M, Wolf MM. Optimal Omeprazole Dosing and Symptom Conb:ol: A Randomized Controlled Trial (OSCAR Trial). Dig Dis Sci. 2019 Jan;64(1):158-166.
  17. Yamasaki T, Fass R. Functional Heartburn. Gastroenterology & Endoscopy News 2019, April, 1-8.
  18. Yamasaki T, Quan SF, Fass R. The effect of sleep deprivation on esophageal acid exposure of healthy controls and patients with gastroesophageal reflux disease. Neurogastroenterol Motil 2019;31(12):e13705. doi: 10.1111/nmo.13705.

 

  1. Abdallah J, George N, Yamasaki T, Ganocy S, Fass R. Most patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy also have functional esophageal disorders. Clin Gastroenteal Hepatol 2018 (in press)
  2. Abdallah J, George N, Yamasaki T, Ganocy S, Fass R. Most patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy also have functional esophageal disorders. Clin Gastroenteal Hepatol 2019;17:1073-1080.
  3. Akinsiku 0, Yamasaki T, Brunner S, Ganocy S, Fass R. High resolution versus conventional esophageal manometry in the assessment of esophageal motor disorders in patients withnoncardiac chest pain. Neurogastroenterol Motil 2018; 30:e13282.
  4. Bandyopadhyay N, Fass R, Yamasaki T, Hemmond C. Pocket Hand- book of esophageal disorders. Springer 2018.
  5. Calles-Escandon J, Koch KL, Hasler WL, Van Natta ML, Herman WH etal.  Safety and efficacy of Sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic Gastroparesis, PLOS ONE 2018;13:e0194759.
  6. Domingues G, Prado J, Fass R. Refractory Heartburn – A challenging problem in clinical practice. Dig Dis Sci 2018; 63:577-82
  7. Fass OZ, Fass R. Overlap between GERD and functional esophageal disorders – a pivotal mechanism for treatment failure. Cur treat opt Gastroenterol 2018 (in press)
  8. Fass R, Shibli F, Tawil J. Diagnosis and Management of functional chest pain in the Rome IV era. J Neurogastroenterol Motil 2019; 25:487-98.
  9. Fass R. Digestive diseases self-education program (DDSEP-9) American Gastroenterological Association - 25 questions - Motility and Neurogastroenterology 2018.
  10. Fass R. Endoscopic treatments for GERD. Gastroenterol Hepatol 2019:15:555-57.
  11. Gyawali CP, Fass R. Current and new treatments for gastroesophageal reflux disease. Gastroenterolgy 2018; 154:302-318
  12. Kurin M, Bielefeldt K, Levinthal DJ. Prevalence of Nausea and Vomiting in Adults Using Ropinirole: A Systematic Review and Meta-Analysis. Dig Dis Sci. 2018 Mar;63(3):687-693
  13. Kurin M, Fass R. Management of Gastroesophageal Reflux Disease in The Elderly Patient. Drug Age 2019; 25: 687-98.
  14. Laique S, Singh T, Dornblaser D, Gadre A, Rangan V, Fass R, Kirby D, Chatterjee S, Gabbard S. Patient characteristics and associated systematic diseases in patients with esophageal absent contractility. J clin Gastroenterol 2019;53:184-190.
  15. Niu B, Kim B, Limketkai BN, Sun J, Li Z, Wore ta T, Chen PH. Mortality from Spontaneous Bacterial Peritonitis Among Hospitalized Patients in the USA. Dig Dis Sci. 2018 May;63(5):1327-1333.
  16. Niv Y, Ho SB, Fass R, Rokkas T. Mucin expression in the esophageal malignant and premalignant states - A systematic review and meta- analysis. J Clin Gastroenterol 2018; 52:91-96
  17. Rangan V, George NS, Khan F, Geng Z, Kichler A, Gabbard S, Gittlem H, Fass R. Severity of ineffective esophageal motility (IEM) is associated with utilization of skeletal muscle relaxants. Neurogastroenterol Mitil 2018;30:e13235.
  18. Rangan V, George NS, Khan F, Geng Z, Kichler A, Gabbard S, Gittlem H, Fass R. Severity of ineffective esophageal motility (IEM) is associated with utization of skeletal muscle relaxants. Neurogastroenterol Mitil 2018;30:e13235.
  19. Sandhu D, Fass R. Stress and Gastroesophageal reflux disease. Med Sci 2018 (in press)
  20. Sandhu D, Fass R. Stress and Gastroesophageal reflux disease. NTSN HS 2018, 54(2):10-15 Sandhu DS, Fass R. Stretta therapy in the management of gastroesophageal reflux disease (GERD). Ann Esoph 2019; 2:1:1-11.\
  21. Sandhu DS, Fass R. Current trends in the management of GERD Gut & Liver 2018;12:7-16
  22. Tawil J, Fass R. Globus: current concepts and dilemmas. J Clin Gastroenterol 2018;52:845-52
  23. Yamasaki T, Hemmond C, Eisa M, Ganocy S, Fass R. The changing epidemiology of GERD - Are patients getting younger? Journal Neurogastroenterol Motil 2018; 24:559-569.
  24. Tawil J, Fass R. Globus: current concepts and dilemmas. J Clin Gastroenterol 2018;52:845-52 Yamasaki T, Hemmond C, Eisa M, Ganocy S, Fass R. The changing epidemiology of GERD - Are patients getting younger? Journal Neurogastroenterol Motil 2018; 24:559-569.
  25. Waghray A, Waghray N, Perzynski AT, Votruba M, Wolfe MM. Optimal Omeprazole Dosing and Symptom Control: A Randomized Controlled Trial (OSCAR Trial). Dig Dis Sci. 2018 Aug 9.doi:10.1007/d10620-018-5235-9 [Epub ahead of print]
  26. Yadlapati R, Vaezi MF, Vela M, Spechler SJ, Shaheen N, Richter J, Lacy BE Katzka D, Datz PO, Kahrilas P, Gyawali CP, Gerson L, Fass R, Castell DO, Craft J, Hillman L, Pandolfino JE. Management options for patients with proven GERD and persistent symptoms on proton pump inhibitors: Recommendations from an expert panel. AM J Gastroenterol 2018; 113:980-86
  27. Yamasaki T, Fass R. Functional Heartburn. Gastroenterology & Endoscopy News 2018, May, 1-8.The Israeli Neurogastroenterology Society and Israeli Gastroenterological Association GERD Guidelines for the primary care physician member of the GI forum.
  28. Yamasaki T, Fass R. Reflux Hypersensitivity – A new functional esophageal disorder J Neurogastroenterol Motil 2018; 23:495-503 
  29. Yamasaki T, Fass R. Reflux hypersensitivity – What’s in the name? Neurogastro LATAM Rev. 2018; 2:1-13
  30. Yamasaki T, Hemmond C, Eisa M, Ganocy S, Fass R. The changing epidemiology of GERD - Are patients getting younger? Journal Neurogastroenterol Motil 2018; 24:559-569
  31. Yamasaki T, Quan SF, Fass R. The effect of sleep deprivation on esophageal acid exposure of healthy controls and patients with gastroesophageal reflux disease. Neurogastroenterol Motil 2019;31(12):e13705. doi: 10.1111/nmo.13705.

  1. Dudley-Brown S, Fass R, Fedler B, Sheeler R. Clinical Roundtable review - Rational counsel on the benefit to risk ratio of PPI therapy. Gastroenterology & Endoscopy news 2017:1-8.
  2. Fass R, Cahn F, Scotti DJ, Gregory DA. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of GERD. Surg Endosc 2017; 31:4865-82
  3. Fass R, Frazier R. The role of Dexlansoprazole in the management of GERD. Ther Ad Gastroenterol 2017;10:243-51
  4. Fass R, Rass SS. Psychological comorbidity and chronic heartburn – which is the chicken, and which is the egg? Dig Dis Sci 2017; 62:823-25.
  5. Fass R. Accepting the torch. J Clin Gastroenterol 2017;5:1
  6. Fass R. An overview of transoral incisionless fundoplication and magnetic sphincter augmentation for GERD. Gastroenterol Hepatol 2017;13:50-52.
    Fass R. GERD testing: conduct off therapy, AGA Perspectives 2017;5-7.
  7. George NS, Rangan V, Geng Z, Khan F, Frazier R, Kichler A, Gabbard S, Ganocy S, Fass R.  Distribution of esophageal motor disorders in diabetic patients with dysphagia. J Clin Gastroenterol 2017; 51:890-895
  8. Laique S, Singh T, Dornblaser D, Gadre A, Rangan V, Fass R, Kirby D, Chatterjee S, Gabbard S. Patient characteristics and associated systematic diseases in patients with esophageal absent contractility. J clin Gastroenterol 2017 (in press)
  9. Syed A, Frazier R, Maradey-Romero C, Fass R. The relationship between eosinophilic esophagitis and esophageal cancer. Dis Esoph 2017; 30:1-5 (editor’s choice)
  10. Yamasaki T, Fass R. Functional heartburn - An update. Gastroenterol Hepatol 2017; 12:725- 34.
  11. Yamasaki T, Fass R. Non cardiac chest pain (NCCP): Diagnosis and management. Curr opin Gastroenterol 2017; 33:293-300
  1. Aziz Q, Fass R, Gyawali CP, Miwa H, Pandolfino JE, et al. Functional Esophageal disorders. Gastroenterology 2016;150:1368-1379
  2. Khan F, Maradey-Romero C, Ganocy S, Frazier R, Fass R. Utilisation of surgical dundoplication for patinets with gastro-oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013. Aliment Phar; 2016;43(11):1124-31.
  3. Abdallah J, Fass R. Progression of Jackhammer Esophagus to Achalasia: Author's Reply. J Neurogastroenterol Motil. 2016;30:22(2)350
  4. Pantham G, Ganesan S, Einstadter D, Jin G, Weinberg A, Fass R Assessment of the incidence of squamous cell papilloma of the esophagus and the presence of high-risk human papilloma virus. Dis Esophagus. 2016
  5. Heading RC, Thomas EC, Sandy P, Smith G, Fass R, Hungin PS. Discrepancies between upper GI symptoms described by those who have them and their identification by conventional medical terminology: a survey of sufferers in four countries. J Gastro Enterol 2016;28(4):455-62
  6. Abdallah J, Fass R. Progression of Jackhammer Esophagus to Type II Achalasia. J Neurogastroenterol Motil. 2016 31;22:153-6
  7. George N, Abdallah J, Maradey-Romero C, Gerson L, Fass R. Review article: the current treatment of non-cardiac chest pain. Aliment Pharmacol Ther 2016;43:213-39
  8. Gabbard SL, Fass R, Maradey-Romero C, Gingold Belfer R, Dickman R. Identifying Minimal Changes in Nonerosive Reflux Disease: Is the Pay Worth the Labor? J Clin Gastroenterol 2016;50(1):11-6.
  9. Jha LK, Fass R, Gadam R, Maradey-Romero C, Nasrollah L, Hershcovici T, Quan SF, Dickman R,, The Effect of Ramelteon on Heartburn Sypmtoms of Patients with Gastroesophageal Reflux Disease and Chronic Insomnia: A Pilot Study. J Clin Gastroenterol 2016;50(2):e19-24.
  10. Tan VP, Wong BC, Wong WM, Leung WK, Tong D, Yuen MF, Fass R. Gastroesophageal Reflux Disease: Cross-Sectional Study Demonstrating Rising Prevalence in a Chinese Population. J Clin Gastroenterol 2016;50(1):el-7
  11. Waghray A, Michel-Calderon A, Kyprianou A, Waghray N. Severe hemorrhagic gastritis after percutaneous endoscopic gastrostomy tube placement. Ann Gastroenterol 2016;29(2):226
  12. Hassan T, Khan F, Kyprianou A. A Not So Benign Abdomen! Gastroenterol 2016;150(2):el-2
  13. Waghray A, Waghray N, Khallafi H, Menon KV. Vaccinating Adult Patients with Cirrhosis: Trends over a Decade in the United States. Gastroenterol Res Pract. 2016;2016:5795712
  14. Lee TH, Rangan V, Khallafi H. A Case of Sphenoid Sinus Metastasis in Hepatocellular Carcinoma. Hepatology 2016;63(6):2050-3
  15. Waghray A, Jain A, Waghray N. Colorectal cancer screening in African Americans: practice patterns in the United States. Are we doing enough?Gastroenterol Rep 2016;4(2):136-40
  16. Waghray A, George N, Waghray N. Gastrointestinal pseudomelanosis. Ann Gastroenterol 2016;29(1):92
  17. Sandhu D, Fass R. The Role of Chemoprevention in Barrett's esophagus. Gastroenterol and Esdoscop News, 2016:11-16
  18. Rodriguez-Torres M, Lawitz E, Yangco B, Jefffers L, Han SH, Thuluvath PJ, Rustgi V, Harrison S, Ghalib R, Vierling JM, Luketic V, Zamor PJ, Ravendhran N, Morgan TR, Pearlman B, O'Brien C, Khallafi H, Pyrsopoulos N, Kong G, McPhee F, Yin PD, Hughes E, Treitel M. Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection. Ann Hepatol 2016; 15(6):834-845
  19. Khan F, Maradey-Romero C, Ganocy S, Frazier R, Fass R. Utilisation of surgical fundoplication for patients with gastro-oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013. Aliment Pharmacol Ther 2016, 43(11):1124-31
  20. Aziz Q, Fass R, Gyawali P, Miwa H, Pardolfino JE, et al.  Functional Esophageal disorders. Gastroenterology 2016;150:1368-1379
  21. Frazier RD, Fass R. Editorial: management of eosinophilic oesophagitis - efficacy vs effectiveness. Aliment Pharmacol Ther 2016;44(2):198-9
  22. Waghray A. Waghray N, Khallafi H, Menon KV. Vaccinating Adult Patients with Cirrhosis: Trends over a Decade in the United States. Gastroenterol Res Pract. 2016;2016:5795712. Doi: 10.1155/2016/5795712/ Epub 2016 April 30
  23. Waghray A, Jain A, Waghray N. Colorectal cancer screening in African Americans” practice patterns in the United States. Are we doing enough? Gastroenterol Rep (Oxf). 2016 May;4(2):136-40. Doi:10.1093/gastro/gow005.Epub 2016 Apr 11.
  24. Waghray A, Michel-Calderon A, Kyprianou A, Waghray N. Severe hemorrhagic gastritis after percutaneous endoscopic gastrostomy tube placement. Ann Gastroenterol. 2016 Apr-Jun; 29(2):226. Doi: 10.20524/aog.2016.00174.
  25. Rodriguez-Torrez M, Lawitz E, Yangco B, Jeffers L, Han SH, Thuluvath PJ, Rustgi V, Harrison S, Ghalib R, Vierling JM, Luketic V, Zamor PJ, Ravendhran N, Morgan TR, Pearlman B, O’Brien C, Khallafi H, Pyrsopoulos N, Kong G, McPhee F, Yin PD, Hughes E, Treitel M. Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection. Ann Hepatol. 2016 Nov-Dec 2016;15(6):834-845.
  26. Waghray A. Waghray N, Khallafi H, Menon KV. Vaccinating Adult Patients with Cirrhosis: Trends over a Decade in the United States. Gastroenterol Res Pract. 2016;2016:5795712. Doi: 10.1155/2016/5795712/ Epub 2016 April 30
  27. Waghray A, Jain A, Waghray N. Colorectal cancer screening in African Americans” practice patterns in the United States. Are we doing enough? Gastroenterol Rep (Oxf). 2016 May;4(2):136-40. Doi:10.1093/gastro/gow005.Epub 2016 Apr 11.
  28. Waghray A, Michel-Calderon A, Kyprianou A, Waghray N. Severe hemorrhagic gastritis after percutaneous endoscopic gastrostomy tube placement. Ann Gastroenterol. 2016 Apr-Jun; 29(2):226. Doi: 10.20524/aog.2016.00174.
  29. Rodriguez-Torrez M, Lawitz E, Yangco B, Jeffers L, Han SH, Thuluvath PJ, Rustgi V, Harrison S, Ghalib R, Vierling JM, Luketic V, Zamor PJ, Ravendhran N, Morgan TR, Pearlman B, O’Brien C, Khallafi H, Pyrsopoulos N, Kong G, McPhee F, Yin PD, Hughes E, Treitel M. Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection. Ann Hepatol. 2016 Nov-Dec 2016;15(6):834-845
MetroHealth Logo